The CPhI Worldwide annual summary warns that US trade laws still show too much favour for big pharma
One of its authors, Dilip Shah, CEO at Vision Consulting Group warns that the reauthorisation of the Trade Priorities and Accountability Act of 2015 will fast track the mega trade agreements that are poised to have the unwanted effect of significantly slowing global access to generics.